SLS sellaslifesciences.com: Sof marja

SELLAS Life Sciences Group (SLS) kompaniyasining rasmiy ramzlari

Sotuv marjasi dinamikasi noyob saraton vaksinalari tomonidan boshqariladigan monopol narx belgilash imkoniyati bilan bog'liq. Biroq, naqd pul yetishmovchiligi va so'nggi bosqichdagi sinovlar xarajatlari SELLAS Life Sciences (SLS) kompaniyasini tashqi investitsiyalarni qidirishga majbur qilmoqda. Joriy ko'rsatkich 0.00 darajasida bo'lib, bu yakuniy sinovlarning muvaffaqiyatsizligi xavflarini va daromadsizlik tufayli listingdan chiqarilish tahdidini ko'rsatadi. Ushbu grafik investorlarga ortib borayotgan kredit tahdidlarini o'z vaqtida aniqlashga yordam beradi.

SLS: SELLAS Life Sciences Group Sof foyda normasi 04.07.2022 - 19.11.2026

sellaslifesciences.com (SLS) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

Kompaniyaning umumiy tahlili:SELLAS Life Sciences Group, Inc. - SLS
SELLAS Life Sciences yetakchi tovari

Sof foyda marjasi barcha operatsion va soliq xarajatlari chegirib tashlanganidan keyin har bir dollar daromadidan qolgan foyda qismini o'lchaydi va kompaniyaning kapital barqarorligini belgilaydi. O'rtacha savdo marjasini tahlil qilish orqali investor SELLAS Life Sciences (SLS) kompaniyasining filtratsiya tizimlarini modernizatsiya qilish va immuno-onkologiya laboratoriyalarida energiyani tejashni o'z ichiga olgan ESG muvofiqlik xarajatlari fonidagi samaradorligini baholaydi.

Raqobatdosh kompaniyalar tahlili

ONC: Sotuvning sof marjinal rentabelligi|Sof marja Halozyme Inc. (HALO)|Sof marja RevMed|Sotuvning sof rentabelligi AAPG (Ascentage Pharma Group)|Sotuvning sof marjinal rentabelligi CGON|UroGen Pharma - Sotuvning sof rentabelligi|Bicara Therapeutics - Sof foyda bo'yicha sotuv rentabelligi|Sotuvning sof marjinal rentabelligi Personalis Inc PSNL|Erasca Oncology - Sotuvning sof marjinal rentabelligi|Sof foyda normasi DCTH (Delcath Corp)|YMAB: Sotuvning sof marjinal rentabelligi|AURA - Kompaniya sotuv marjasi|CADL (Candel Therapeutics Inc.) - Sotuvning sof marjinal rentabelligi|Sotuvning sof rentabelligi ARAY (Accuray)|Sotuvning sof marjinal rentabelligi ACTU|CTOR - Sof marja|Sotuvning sof marjinal rentabelligi HURA (TuHURA Biosciences, Inc.)|Sof foyda normasi TARA|FATE: Sof foyda bo'yicha sotuv rentabelligi|WHWK (aadibio.com) - Sotuvning sof rentabelligi|TCRX (TScan Therapeutics, Inc.) - Sof foyda bo'yicha sotuv rentabelligi|Sof marja Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Sotuvning sof marjinal rentabelligi|CVM (CEL-SCI Corporation) - Kompaniyaning sof rentabelligi|Sotuvning sof marjinal rentabelligi OSTX|Sotuvning sof marjinal rentabelligi Radiopharm Theranostics Ltd (RADX)|Sotuvning sof marjinal rentabelligi ARTV (Artiva Biotherapeutics)|Sotuvning sof marjinal rentabelligi Adlai Nortye Ltd. ANL|Veru Inc - Sotuvning sof marjinal rentabelligi|Kompaniya sotuv marjasi Tempest Therapeutics TPST|XLO: Sotuvning sof marjinal rentabelligi|Enochian BioSciences (RENB) - Sotuvning sof marjinal rentabelligi|Sof foyda bo'yicha sotuv rentabelligi MURA|Kairos Pharma Ltd - Sof foyda marjasi|Sotuvning sof marjinal rentabelligi OKUR|CytoMed Therapeutics Limited (GDTC) - Sof foyda bo'yicha marjinallik|Sotuvning sof marjinal rentabelligi CRIS (Curis, Inc.)|APLM: Sotuvning sof rentabelligi|Tharimmune Corporation - Sotuvning sof marjinal rentabelligi|ADVB: Sof marja|GNPX: Sotuvning sof marjinal rentabelligi|CLDI (Calidi Biotherapeutics Inc.) - Sof marja|Sof marja Sunshine Biopharma, Inc.|Sotuvning sof marjinal rentabelligi xeneticbio.com|Sof marja Salarius (SLRX)|Sof foyda bo'yicha sotuv rentabelligi Purple Biotech PPBT|Sof marja American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Sof marja|Checkpoint Therapeutics Inc. - Sotuvning sof marjinal rentabelligi|Sof foyda normasi ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Sof foyda bo'yicha sotuv rentabelligi|Ikena Oncology, Inc. - Sof foyda normasi|Sof foyda bo'yicha sotuv rentabelligi NTBL|VIRX: Sof foyda normasi|Sof marja MorphoSys Corporation (MOR)|NAYA - Sof marja|Sotuvning sof marjinal rentabelligi AAPGV (Ascentage)